UB Paderborn / Katalog / Suche / in CDI

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 ( ) autocrine loop in human leukemia cells MOLT-4

Leukemia, 2003-01, Vol.17 (1), p.52-59

2003

Link zum Volltext

Verfügbarkeit prüfen

The microtubule-affecting drug paclitaxel has antiangiogenic activity

Clinical cancer research, 1996-11, Vol.2 (11), p.1843-1849

1996

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic activity of aplidine, a new agent of marine origin

British journal of cancer, 2004-06, Vol.90 (12), p.2418-2424

2004

Link zum Volltext

Verfügbarkeit prüfen

Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Thrombosis research, 2012-04, Vol.129, p.S193-S193

2012

Link zum Volltext

Verfügbarkeit prüfen

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Thrombosis research, 2021-04, Vol.200, p.S58-S59

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

JNCI : Journal of the National Cancer Institute, 1995-02, Vol.87 (4), p.293-298

1995

Link zum Volltext

Verfügbarkeit prüfen

Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells

The American journal of pathology, 2002-02, Vol.160 (2), p.673-680

2002

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow‐up study

Rheumatology (Oxford, England), 2003-02, Vol.42 (2), p.349-352

2003

Link zum Volltext

Verfügbarkeit prüfen

Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH

Neoplasia (New York, N.Y.), 2006-02, Vol.8 (2), p.96-103

2006

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

The American journal of pathology, 2000-11, Vol.157 (5), p.1703-1711

2000

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.846-IN16

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulator

Clinical cancer research, 2004-07, Vol.10 (14), p.4813-4821

2004

Link zum Volltext

Verfügbarkeit prüfen

Vascular-targeting activity of ZD6126, a novel tubulin-binding agent

Cancer research (Chicago, Ill.), 2003-04, Vol.63 (7), p.1534-1537

2003

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas

International journal of cancer, 2001-01, Vol.91 (2), p.241-247

2001

Link zum Volltext

Verfügbarkeit prüfen

The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis

Clinical cancer research, 2006-03, Vol.12 (6), p.1839-1849

2006

Link zum Volltext

Verfügbarkeit prüfen

PO-88 Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Thrombosis research, 2012-04, Vol.129, p.S193-S193

2012

Link zum Volltext

Verfügbarkeit prüfen

Somatostatin 28 and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationships and evidence for differential coexistence

Neuroscience, 1987-07, Vol.22 (1), p.49-73

1987

Link zum Volltext

Verfügbarkeit prüfen

BAY 12-9566, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity

Clinical cancer research, 1999-11, Vol.5 (11), p.3603-3607

1999

Link zum Volltext

Verfügbarkeit prüfen

Potential Antagonism of Tubulin-Binding Anticancer Agents in Combination Therapies

Clinical cancer research, 2005-04, Vol.11 (7), p.2720-2726

2005

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic and Antitumor Activity of IDN 5390, a New Taxane Derivative

Clinical cancer research, 2002-04, Vol.8 (4), p.1182-1188

2002

Link zum Volltext

Verfügbarkeit prüfen

p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis

Oncogene, 2001-11, Vol.20 (50), p.7293-7300

2001

Link zum Volltext

Verfügbarkeit prüfen

Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions

The Journal of pathology, 1999-05, Vol.188 (1), p.76-81

1999

Link zum Volltext

Verfügbarkeit prüfen

Posttranscriptional Stimulation of Endothelial Cell Matrix Metalloproteinases 2 and 1 by Endothelioma Cells

Experimental cell research, 2000-08, Vol.258 (2), p.384-394

2000

Link zum Volltext

Verfügbarkeit prüfen

Electrochemical Oxidation of Benzyl Chlorides: A New Synthesis of 5-Methyl-2-Pyrazinecarboxylic Acid

Synthesis (Stuttgart), 1990, Vol.1990 (3), p.207-208

1990

Link zum Volltext

Verfügbarkeit prüfen

28 ORAL Imidazole derivatives with vascular disrupting activity

European journal of cancer supplements, 2006-11, Vol.4 (12), p.12-13

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 ( ) autocrine loop in human leukemia cells MOLT-4

The microtubule-affecting drug paclitaxel has antiangiogenic activity

Antiangiogenic activity of aplidine, a new agent of marine origin

Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells

Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow‐up study

Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH

Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo

Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulator

Vascular-targeting activity of ZD6126, a novel tubulin-binding agent

Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas

The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis

PO-88 Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression

Somatostatin 28 and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationships and evidence for differential coexistence

BAY 12-9566, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity

Potential Antagonism of Tubulin-Binding Anticancer Agents in Combination Therapies

Antiangiogenic and Antitumor Activity of IDN 5390, a New Taxane Derivative

p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis

Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions

Posttranscriptional Stimulation of Endothelial Cell Matrix Metalloproteinases 2 and 1 by Endothelioma Cells

Electrochemical Oxidation of Benzyl Chlorides: A New Synthesis of 5-Methyl-2-Pyrazinecarboxylic Acid

28 ORAL Imidazole derivatives with vascular disrupting activity

Suchergebnisse filtern